← Evidence map

ReviewTargeted oncology2017

Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars.

Lee S Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

86 papers cite itlatest 60 shown

2017
…
2019
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28801849